Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Proceeds from the more than $9 million sale to strengthen the CDMO’s balance sheet.
August 16, 2022
By: Tim Wright
Editor-in-Chief, Contract Pharma
Societal CDMO, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, has signed a sales and purchase agreement to sell approximately 121 acres of lakefront land to David Weekley Homes, an established homebuilder, for $9,075,000.00. The land is located adjacent to Societal’s manufacturing facility in Gainesville, GA, and is being sought by David Weekley Homes, which operates in 19 cities across the U.S., for residential development. The closing of the sale is subject to completion of standard due diligence and other customary conditions. Subject to completion of diligence, Societal CDMO expects the sale to close in the second half of 2023 and intends to use the proceeds from the sale to strengthen its balance sheet by paying down a portion of its outstanding debt. “A core component of Societal’s forward-looking growth strategy is the continuous strengthening of our balance sheet to provide the company the sturdiest foundation from which to operate. Our ownership of these approximately 121 acres of lakefront property provides Societal CDMO the unique opportunity to monetize a valuable, non-core business asset and utilize the capital that is generated to offset a portion of the company’s debt,” said Ryan Lake, chief financial officer, Societal CDMO. “We believe that this is a particularly prudent move in light of the challenging economic environment that is currently impacting not only those in the life sciences industry but the broader global market. We look forward to the closing of this transaction and continuing to execute against our broader corporate growth strategy.” Societal CDMO is also in the process of pursuing a second real estate transaction intended to further strengthen the company’s financial position. This second transaction is focused on the sale and lease back of its buildings and a portion of the company’s remaining land on its Gainesville campus. Discussions with prospective buyers are advancing and the company is aiming to close the sale and lease back deal by the end of 2022. The company expects the total proceeds from both real estate transactions to be between $40 million and $50 million, and intends to utilize these proceeds to reduce its debt and significantly improve its debt capital structure, putting the company on a path toward refinancing the debt at a lower cost of capital.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !